4//SEC Filing
Westgate Mark 4
Accession 0001437749-18-007107
CIK 0000811212other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 5:38 PM ET
Size
5.5 KB
Accession
0001437749-18-007107
Insider Transaction Report
Form 4
Westgate Mark
Director
Transactions
- Disposition to Issuer
Stock Options
2018-04-16−34,000→ 20,000 totalExercise: $3.00Exp: 2028-12-31→ Common Stock (34,000 underlying)
Footnotes (2)
- [F1]The option vests in two (2) installments. 13,500 shares on December 31, 2018 and 6,500 shares on December 31, 2019. Under the terms of the award agreement, no portion of the option may be exercised unless and until the stockholders of the Company approve the November 2017 amendment to our 2016 Equity Incentive Plan and only if such amendment is approved by the stockholders within one year of the adoption of the amendment.
- [F2]34,000 shares of the stock options were cancelled by mutual agreement of the reporting person and Cesca Therapeutics Inc. The reporting person received no cash consideration for the cancellation.
Documents
Issuer
CESCA THERAPEUTICS INC.
CIK 0000811212
Entity typeother
Related Parties
1- filerCIK 0001347080
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 5:38 PM ET
- Size
- 5.5 KB